Point of Care (PoC) Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays); By End-Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory); By Product; By Regions; Segment Forecast, 2021 - 2028

Published Date: Jan 2021
Pages: 153
Format: PDF
Report ID: PM1099
Base Year: 2020
Historical Data: 2016 - 2019

Report Scope

Point of Care (PoC) Diagnostics, Product Outlook (Revenue - USD Million, 2016 – 2028)

Glucose Testing
Hb1Ac Testing
Coagulation
Fertility
Infectious Diseases
- HIV
- Clostridium Difficile
- HBV
- Pneumonia or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV)
- HPV
- Influenza/Flu
- HCV
- MRSA
- TB and Drug-Resistant TB
- HSV
- Others
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug Abuse Testing
Urinalysis

Point of Care (PoC) Diagnostics, Platform Outlook (Revenue - USD Million, 2016 – 2028)

Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays

Point of Care (PoC) Diagnostics, End-Use Outlook (Revenue - USD Million, 2016 – 2028)

Clinics
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinic
Hospitals
Home
Assisted Living Healthcare Facilities
Laboratory

Point of Care (PoC) Diagnostics Regional Outlook (Revenue - USD Million, 2016 – 2028)

North America
- Product Outlook
  - Glucose Testing
  - Hb1Ac Testing
  - Coagulation
  - Fertility
  - Infectious Diseases
    - HIV
    - Clostridium Difficile
    - HBV
    - Pneumonia or Streptococcus Associated Infections
    - Respiratory Syncytial Virus (RSV)
    - HPV
    - Influenza/Flu
    - HCV
    - MRSA
    - TB and Drug-Resistant TB
    - HSV
    - Others
  - Cardiac Markers
  - Thyroid Stimulating Hormone
  - Hematology
  - Primary Care Systems
  - Decentralized Clinical Chemistry
  - Feces
  - Lipid Testing
  - Cancer Marker
  - Blood Gas/Electrolytes
  - Ambulatory Chemistry
  - Drug Abuse Testing
  - Urinalysis
- Platform Outlook
  - Lateral Flow Assays
  - Dipsticks
  - Microfluidics
  - Molecular Diagnostics
  - Immunoassays
- 最终用途前景
  - Clinics
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinic
  - Hospitals
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratory
Europe
- Product Outlook
  - Glucose Testing
  - Hb1Ac Testing
  - Coagulation
  - Fertility
  - Infectious Diseases
    - HIV
    - Clostridium Difficile
    - HBV
    - Pneumonia or Streptococcus Associated Infections
    - Respiratory Syncytial Virus (RSV)
    - HPV
    - Influenza/Flu
    - HCV
    - MRSA
    - TB and Drug-Resistant TB
    - HSV
    - Others
  - Cardiac Markers
  - Thyroid Stimulating Hormone
  - Hematology
  - Primary Care Systems
  - Decentralized Clinical Chemistry
  - Feces
  - Lipid Testing
  - Cancer Marker
  - Blood Gas/Electrolytes
  - Ambulatory Chemistry
  - Drug Abuse Testing
  - Urinalysis
- Platform Outlook
  - Lateral Flow Assays
  - Dipsticks
  - Microfluidics
  - Molecular Diagnostics
  - Immunoassays
- End-Use Outlook
  - Clinics
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinic
  - Hospitals
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratory
Asia Pacific
- Product Outlook
  - Glucose Testing
  - Hb1Ac Testing
  - Coagulation
  - Fertility
  - Infectious Diseases
    - HIV
    - Clostridium Difficile
    - HBV
    - Pneumonia or Streptococcus Associated Infections
    - Respiratory Syncytial Virus (RSV)
    - HPV
    - Influenza/Flu
    - HCV
    - MRSA
    - TB and Drug-Resistant TB
    - HSV
    - Others
  - Cardiac Markers
  - Thyroid Stimulating Hormone
  - Hematology
  - Primary Care Systems
  - Decentralized Clinical Chemistry
  - Feces
  - Lipid Testing
  - Cancer Marker
  - Blood Gas/Electrolytes
  - Ambulatory Chemistry
  - Drug Abuse Testing
  - Urinalysis
- Platform Outlook
  - Lateral Flow Assays
  - Dipsticks
  - Microfluidics
  - Molecular Diagnostics
  - Immunoassays
- End-Use Outlook
  - Clinics
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinic
  - Hospitals
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratory
Latin America
- Product Outlook
  - Glucose Testing
  - Hb1Ac Testing
  - Coagulation
  - Fertility
  - Infectious Diseases
    - HIV
    - Clostridium Difficile
    - HBV
    - Pneumonia or Streptococcus Associated Infections
    - Respiratory Syncytial Virus (RSV)
    - HPV
    - Influenza/Flu
    - HCV
    - MRSA
    - TB and Drug-Resistant TB
    - HSV
    - Others
  - Cardiac Markers
  - Thyroid Stimulating Hormone
  - Hematology
  - Primary Care Systems
  - Decentralized Clinical Chemistry
  - Feces
  - Lipid Testing
  - Cancer Marker
  - Blood Gas/Electrolytes
  - Ambulatory Chemistry
  - Drug Abuse Testing
  - Urinalysis
- Platform Outlook
  - Lateral Flow Assays
  - Dipsticks
  - Microfluidics
  - Molecular Diagnostics
  - Immunoassays
- End-Use Outlook
  - Clinics
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinic
  - Hospitals
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratory
Middle East & Africa
- Product Outlook
  - Glucose Testing
  - Hb1Ac Testing
  - Coagulation
  - Fertility
  - Infectious Diseases
    - HIV
    - Clostridium Difficile
    - HBV
    - Pneumonia or Streptococcus Associated Infections
    - Respiratory Syncytial Virus (RSV)
    - HPV
    - Influenza/Flu
    - HCV
    - MRSA
    - TB and Drug-Resistant TB
    - HSV
    - Others
  - Cardiac Markers
  - Thyroid Stimulating Hormone
  - Hematology
  - Primary Care Systems
  - Decentralized Clinical Chemistry
  - Feces
  - Lipid Testing
  - Cancer Marker
  - Blood Gas/Electrolytes
  - Ambulatory Chemistry
  - Drug Abuse Testing
  - Urinalysis
- Platform Outlook
  - Lateral Flow Assays
  - Dipsticks
  - Microfluidics
  - Molecular Diagnostics
  - Immunoassays
- End-Use Outlook
  - Clinics
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinic
  - Hospitals
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratory

Qualitative Analysis

Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL Analysis
- Value Chain Analysis
- Key market opportunities prioritized
Competitive landscape
- Overview
- Financials
- Product benchmarking
- Latest strategic developments
- Price Trend Analysis

Quantitative Analysis

Market size, estimates, and forecasts from 2020 - 2028
Market size and revenue estimates for platform up to 2028
Market revenue estimates for product up to 2028
Market revenue estimates for end-use up to 2028
Regional market size and forecast up to 2028
Company financials

License and Pricing

Single User - $ 4,950 Multi Users(Up to 20 User)- $ 5,950 Enterprise License - $ 6,950 Buy Now

Purchase Report Sections

Regional analysis
Segmentation analysis
Industry outlook
Competitive landscape

Request for Discount Pricing

Connect With Experts

+1-646-568-9980 sales@polarismarketresearch.com Speak to Analyst Request for Customization

Report Scope

Qualitative Analysis

Quantitative Analysis

License and Pricing

Purchase Report Sections

Connect With Experts

Suggested Report